Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Intarcia Therapeutics

Request full access

Develops innovative therapies aimed at Diabetes

Boston, United StatesFounded 1997Biotech & Life Sciences

About Intarcia Therapeutics

Intarcia Therapeutics is a pioneering company focused on redesigning the treatment of chronic diseases through innovative therapies that integrate medicine with technology. Operating in the biopharmaceutical sector, Intarcia serves patients suffering from chronic conditions, aiming to improve their quality of life with advanced drug delivery systems. The company's core product is the Medici Drug Delivery System, an investigational technology designed to provide consistent and long-term delivery of medication. Intarcia's business model revolves around the development and commercialization of these cutting-edge therapies, generating revenue through partnerships, licensing agreements, and direct sales. By placing patients at the center of their mission, Intarcia is committed to transforming therapeutic categories and setting new standards in chronic disease management.

Source: Dealroom company data

Intarcia Therapeutics in the Boston ecosystem

Live from Dealroom

The Intarcia Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later10 investors entered at this stage

Team profiled 32 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$49M

21 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Intarcia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.